Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000484082 | SCV000568099 | uncertain significance | not provided | 2016-06-14 | criteria provided, single submitter | clinical testing | This variant is denoted CDH1 c.1566-15C>A or IVS10-15C>A and consists of a C>A nucleotide substitution at the -15 position of intron 10 of the CDH1 gene. Multiple in silico models predict this variant to damage the nearby natural acceptor site, and to possibly cause abnormal gene splicing. However, in the absence of RNA or functional studies, the actual effect of this variant is unknown. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. The cytosine (C) nucleotide that is altered is not conserved across species. Based on currently available information, it is unclear whether CDH1 c.1566-15C>A is pathogenic or benign. We consider it to be a variant of uncertain significance. |
Color Diagnostics, |
RCV001185548 | SCV001351797 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-12-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002056754 | SCV002351801 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2023-08-28 | criteria provided, single submitter | clinical testing |